<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gaspari</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Zengarini</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Greco</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Vangeli</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Mastroianni</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports</article-title>. 
  <source>Int. J. Antimicrob. Agents</source>
  <volume>56</volume> (
  <issue>2</issue>), 
  <elocation-id>106023</elocation-id>. 
  <pub-id pub-id-type="doi">10.1016/J.IJANTIMICAG.2020.106023</pub-id>
 </mixed-citation>
</ref>
